Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
EXCLI J ; 19: 1459-1476, 2020.
Article in English | MEDLINE | ID: mdl-33312107

ABSTRACT

The debate about possible adverse effects of bisphenol A (BPA) has been ongoing for decades. Bisphenol F (BPF) and S (BPS) have been suggested as "safer" alternatives. In the present study we used hepatocyte-like cells (HLCs) derived from the human embryonic stem cell lines Man12 and H9 to compare the three bisphenol derivatives. Stem cell-derived progenitors were produced using an established system and were exposed to BPA, BPF and BPS for 8 days during their transition to HLCs. Subsequently, we examined cell viability, inhibition of cytochrome P450 (CYP) activity, and genome-wide RNA profiles. Sub-cytotoxic, inhibitory concentrations (IC50) of CYP3A were 20, 9.5 and 25 µM for BPA, BPF and BPS in Man12 derived HLCs, respectively. The corresponding concentrations for H9-derived HLCs were 19, 29 and 31 µM. These IC50 concentrations were used to study global expression changes in this in vitro study and are higher than unconjugated BPA in serum of the general population. A large overlap of up- as well as downregulated genes induced by the three bisphenol derivatives was seen. This is at least 28-fold higher compared to randomly expected gene expression changes. Moreover, highly significant correlations of expression changes induced by the three bisphenol derivatives were obtained in pairwise comparisons. Dysregulated genes were associated with reduced metabolic function, cellular differentiation, embryonic development, cell survival and apoptosis. In conclusion, no major differences in cytochrome inhibitory activities of BPA, BPF and BPS were observed and gene expression changes showed a high degree of similarity.

2.
Antimicrob Agents Chemother ; 50(8): 2707-12, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16870762

ABSTRACT

The pseudopeptide pyrrolidinedione antibiotics, such as moiramide B, have recently been discovered to target the multisubunit acetyl coenzyme A (acetyl-CoA) carboxylases of bacteria. In this paper, we describe synthetic variations of each moiety of the modularly composed pyrrolidinediones, providing insight into structure-activity relationships of biochemical target activity, in vitro potency, and in vivo efficacy. The novel derivatives showed highly improved activities against gram-positive bacteria compared to those of previously reported variants. The compounds exhibited a MIC(90) value of 0.1 microg/ml against a broad spectrum of Staphylococcus aureus clinical isolates. No cross-resistance to antibiotics currently used in clinical practice was observed. Resistance mutations induced by pyrrolidinediones are exclusively located in the carboxyltransferase subunits of the bacterial acetyl-CoA carboxylase, indicating the identical mechanisms of action of all derivatives tested. Improvement of the physicochemical profile was achieved by salt formation, leading to aqueous solubilities of up to 5 g/liter. For the first time, the in vitro activity of this compound class was compared with its in vivo efficacy, demonstrating a path from compounds weakly active in vivo to agents with significant efficacy. In a murine model of S. aureus sepsis, the 100% effective dose of the best compound reported was 25 mg/kg of body weight, only fourfold higher than that of the comparator molecule linezolid. The obvious improvements achieved by chemical derivatization reflect the potential of this novel antibiotic compound class for future therapy.


Subject(s)
Acetyl-CoA Carboxylase/antagonists & inhibitors , Amides/pharmacology , Anti-Bacterial Agents/pharmacology , Enzyme Inhibitors/pharmacology , Sepsis/drug therapy , Acetamides/pharmacology , Amides/pharmacokinetics , Amino Acid Sequence , Amino Acid Substitution , Animals , Anti-Bacterial Agents/pharmacokinetics , Anti-Infective Agents/pharmacology , Colony Count, Microbial , Disease Models, Animal , Enzyme Inhibitors/pharmacokinetics , Female , Gram-Positive Bacteria/drug effects , Humans , In Vitro Techniques , Linezolid , Male , Mice , Mice, Inbred Strains , Microbial Sensitivity Tests , Molecular Sequence Data , Oxazolidinones/pharmacology , Rats , Rats, Wistar , Solubility , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification , Structure-Activity Relationship , Survival Analysis , Water/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...